PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry
6 December 2023 PanGenomic Health Inc. (“PanGenomic” or the “Company”) PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry Vancouver, British Columbia, Canada, 6 December 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has introduced its point-of-care Vitamin D test for the dental implant industry. "Vitamin D can play a significant role in the success of a dental implant